Protalix BioTherapeutics, Inc. Shares Outstanding (Cover Page)
Protalix BioTherapeutics, Inc. (PLX) had Shares Outstanding (Cover Page) of 80.57 million shares as of 2026-08-01, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-01: Entity Common Stock, Shares Outstanding 80.57M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 80.57M shares.
- 2026-03-01: Entity Common Stock, Shares Outstanding 80.57M shares.
- 2025-11-01: Entity Common Stock, Shares Outstanding 80.42M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-01 | 80.57M shares 10-Q · filed 2026-08-12 |
| 2026-05-01 | 80.57M shares 10-Q · filed 2026-05-13 |
| 2026-03-01 | 80.57M shares 10-K · filed 2026-03-18 |
| 2025-11-01 | 80.42M shares 10-Q · filed 2025-11-13 |
| 2025-08-01 | 79.73M shares 10-Q · filed 2025-08-14 |
| 2025-05-01 | 79.61M shares 10-Q · filed 2025-05-09 |
| 2025-03-14 | 78.03M shares 10-K · filed 2025-03-17 |
| 2024-11-01 | 73.63M shares 10-Q · filed 2024-11-14 |
| 2024-08-01 | 73.54M shares 10-Q · filed 2024-08-14 |
| 2024-05-01 | 73.32M shares 10-Q · filed 2024-05-10 |
| 2024-03-01 | 73.05M shares 10-K · filed 2024-03-14 |
| 2023-11-01 | 72.95M shares 10-Q · filed 2023-11-06 |
| 2023-08-01 | 71.58M shares 10-Q · filed 2023-08-07 |
| 2023-04-30 | 65.41M shares 10-Q · filed 2023-05-04 |
| 2023-02-15 | 57.35M shares 10-K · filed 2023-02-27 |
| 2022-11-10 | 50.67M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 49.75M shares 10-Q · filed 2022-08-15 |
| 2022-05-10 | 47.06M shares 10-Q · filed 2022-05-16 |
| 2022-03-15 | 46.32M shares 10-K · filed 2022-03-31 |
| 2021-11-01 | 45.56M shares 10-Q · filed 2021-11-15 |
| 2021-08-01 | 45.56M shares 10-Q · filed 2021-08-16 |
| 2021-05-10 | 45.38M shares 10-Q · filed 2021-05-14 |
| 2021-04-28 | 45.38M shares 10-K/A · filed 2021-04-30 |
| 2021-03-01 | 45.38M shares 10-K · filed 2021-03-30 |
| 2020-10-15 | 33.34M shares 10-Q · filed 2020-10-29 |
| 2020-08-01 | 32.44M shares 10-Q · filed 2020-08-10 |
| 2020-05-24 | 32.44M shares 10-Q · filed 2020-06-01 |
| 2020-03-01 | 14.84M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 148.38M shares 10-Q · filed 2019-11-07 |
| 2019-08-01 | 148.38M shares 10-Q · filed 2019-08-08 |
| 2019-05-01 | 148.38M shares 10-Q · filed 2019-05-06 |
| 2019-03-01 | 148.38M shares 10-K · filed 2019-03-18 |
| 2018-11-01 | 148.37M shares 10-Q · filed 2019-03-18 |
| 2018-08-01 | 148.18M shares 10-Q · filed 2019-03-18 |
| 2018-05-01 | 145.57M shares 10-Q · filed 2019-03-18 |
| 2018-03-01 | 145.57M shares 10-K · filed 2018-03-06 |
| 2017-11-01 | 139.73M shares 10-Q · filed 2017-11-08 |
| 2017-08-01 | 133.36M shares 10-Q · filed 2017-08-09 |
| 2017-05-01 | 126.50M shares 10-Q · filed 2017-05-10 |
| 2017-03-01 | 124.13M shares 10-K · filed 2017-03-16 |
| 2016-11-01 | 99.93M shares 10-Q · filed 2016-11-09 |
| 2016-08-01 | 99.81M shares 10-Q · filed 2016-08-08 |
| 2016-05-01 | 99.81B shares 10-Q · filed 2016-05-09 |
| 2016-03-01 | 99.81M shares 10-K · filed 2016-03-08 |
| 2015-11-01 | 99.80M shares 10-Q · filed 2015-11-09 |
| 2015-08-01 | 94.15M shares 10-Q · filed 2015-08-10 |
| 2015-05-01 | 93.60M shares 10-Q · filed 2015-05-07 |
| 2015-03-01 | 93.60M shares 10-K · filed 2015-03-12 |
| 2014-11-01 | 93.67M shares 10-Q · filed 2014-11-10 |
| 2014-08-01 | 93.66M shares 10-Q · filed 2014-08-07 |
| 2014-05-01 | 93.61M shares 10-Q · filed 2014-05-08 |
| 2014-03-01 | 93.58M shares 10-K · filed 2014-03-13 |
| 2013-11-01 | 93.56M shares 10-Q · filed 2013-11-07 |
| 2013-08-01 | 93.54M shares 10-Q · filed 2013-08-08 |
| 2013-05-01 | 93.50M shares 10-Q · filed 2013-05-09 |
| 2013-02-15 | 93.50M shares 10-K · filed 2013-02-28 |
| 2012-11-04 | 93.47M shares 10-Q · filed 2012-11-07 |
| 2012-07-30 | 91.92M shares 10-Q · filed 2012-08-03 |
| 2012-05-03 | 91.89M shares 10-Q · filed 2012-05-09 |
| 2012-02-23 | 90.82M shares 10-K · filed 2012-02-27 |
| 2011-11-01 | 85.62M shares 10-Q · filed 2011-11-07 |
| 2011-08-01 | 85.58M shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |